PL3419683T3 - Preparaty i zestawy generujące tlenek azotu - Google Patents

Preparaty i zestawy generujące tlenek azotu

Info

Publication number
PL3419683T3
PL3419683T3 PL17757208T PL17757208T PL3419683T3 PL 3419683 T3 PL3419683 T3 PL 3419683T3 PL 17757208 T PL17757208 T PL 17757208T PL 17757208 T PL17757208 T PL 17757208T PL 3419683 T3 PL3419683 T3 PL 3419683T3
Authority
PL
Poland
Prior art keywords
kits
nitric oxide
oxide generating
generating formulations
formulations
Prior art date
Application number
PL17757208T
Other languages
English (en)
Inventor
Mark E. Meyerhoff
Gergely LAUTNER
Anant BALIJEPALLI
Umadeyi SAJJAN
Hang REN
Original Assignee
The Regents Of The University Of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of Michigan filed Critical The Regents Of The University Of Michigan
Publication of PL3419683T3 publication Critical patent/PL3419683T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17757208T 2016-02-25 2017-02-23 Preparaty i zestawy generujące tlenek azotu PL3419683T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662299850P 2016-02-25 2016-02-25
PCT/US2017/019136 WO2017147295A1 (en) 2016-02-25 2017-02-23 Nitric oxide generating formulations and kits
EP17757208.8A EP3419683B1 (en) 2016-02-25 2017-02-23 Nitric oxide generating formulations and kits

Publications (1)

Publication Number Publication Date
PL3419683T3 true PL3419683T3 (pl) 2022-01-17

Family

ID=59686544

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17757208T PL3419683T3 (pl) 2016-02-25 2017-02-23 Preparaty i zestawy generujące tlenek azotu

Country Status (8)

Country Link
US (1) US20190054038A1 (pl)
EP (1) EP3419683B1 (pl)
JP (1) JP7168958B2 (pl)
CN (2) CN119185266A (pl)
AU (1) AU2017223689B2 (pl)
ES (1) ES2899364T3 (pl)
PL (1) PL3419683T3 (pl)
WO (1) WO2017147295A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019169092A1 (en) * 2018-03-01 2019-09-06 The Regents Of The University Of Michigan Two-part nitric oxide generating topical compositions
US20210386944A1 (en) * 2018-10-12 2021-12-16 Sanotize Research Development Corp. Gas-evolving compositions and container and delivery systems
CA3141349A1 (en) * 2019-06-10 2020-12-17 The Regents Of The University Of Michigan Catheter insert device with powder comprising s-nitrosothiol
US20210052842A1 (en) * 2019-08-23 2021-02-25 NOTA Laboratories, LLC Nitric oxide generating systems for nasal inhalation
US11986597B2 (en) * 2019-08-23 2024-05-21 NOTA Laboratories, LLC Nitric oxide generating systems for inhalation
CN114727915A (zh) * 2019-10-07 2022-07-08 香榭有限公司 用于将一氧化氮递送至皮肤的组合物
CN115279352A (zh) * 2020-04-02 2022-11-01 密歇根大学董事会 尿导管治疗
JP2023523410A (ja) * 2020-04-22 2023-06-05 サノタイズ リサーチ アンド ディベロップメント コープ. 上気道感染症を治療するための組成物および方法
US20240261243A1 (en) * 2020-09-04 2024-08-08 Know Bio, Llc Nitric oxide donors, compositions, and methods of use
KR102602347B1 (ko) * 2022-05-09 2023-11-15 천현수 위장내 발암성 엔-니트로사민 생성 억제 및 장내 산화질소 생성 촉진용 천연 조성물 및 이의 용도
US20240188563A1 (en) * 2022-12-09 2024-06-13 Becton, Dickinson And Company Catheter lock solutions incorporating nitric oxide releasing liposomes
CN116251166A (zh) * 2023-01-18 2023-06-13 南京诺令生物科技有限公司 一种具有抗病毒功效的两相组合物及其应用
US11813287B1 (en) * 2023-03-10 2023-11-14 King Faisal University Covid-19 binding aerosols
WO2025159930A1 (en) * 2024-01-26 2025-07-31 University Of Georgia Research Foundation, Inc. Lock solutions composed of a methanetrisdiazeniumdiolate salt and methods for making and using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678391B2 (en) * 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
JP2009518069A (ja) * 2005-12-02 2009-05-07 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン 組成物、コーティング及びデバイス、並びにそれらの製造方法及び使用方法
US20090311292A1 (en) * 2006-09-14 2009-12-17 Cristalia Produtos Quimicos Farmaceuticos Ltda. Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions
WO2008153762A2 (en) * 2007-05-25 2008-12-18 N30 Pharmaceuticals, Llc S-nitrosothiol formulations and storage systems
US8399005B2 (en) * 2007-10-12 2013-03-19 University Of North Carolina At Chapel Hill Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
JP5351174B2 (ja) * 2007-12-31 2013-11-27 コヴィディエン リミテッド パートナーシップ 消毒剤組成物、方法およびシステム
CN103127504A (zh) * 2011-12-05 2013-06-05 尼奥克斯(文莱)控股有限公司 局部产生一氧化氮的组合物和方法
US20150272988A1 (en) * 2012-03-07 2015-10-01 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2013169538A1 (en) * 2012-05-08 2013-11-14 Albert Einstein College Of Medicine Of Yeshiva University Nanoparticle delivery vehicle for s-nitroso-n-acetyl cysteine and uses thereof
CA2899477C (en) * 2013-02-07 2019-09-17 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability

Also Published As

Publication number Publication date
US20190054038A1 (en) 2019-02-21
EP3419683B1 (en) 2021-10-06
WO2017147295A1 (en) 2017-08-31
EP3419683A1 (en) 2019-01-02
EP3419683A4 (en) 2019-10-09
CN109069701A (zh) 2018-12-21
AU2017223689A1 (en) 2018-08-16
JP2019506419A (ja) 2019-03-07
JP7168958B2 (ja) 2022-11-10
AU2017223689B2 (en) 2021-05-20
ES2899364T3 (es) 2022-03-11
CN119185266A (zh) 2024-12-27

Similar Documents

Publication Publication Date Title
PL3419683T3 (pl) Preparaty i zestawy generujące tlenek azotu
ZA201805805B (en) Formulations and methods
GB2599576B (en) Methods and compositions for generating nitric oxide and uses thereof
IL264813B (en) 2-oxo-imidazopyridines and their use
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
IL253234B (en) Methods for transdifferentiation and methods to use them
GB201706352D0 (en) Methods compositions and uses relating thereto
IL261347A (en) Formulations and printing methods
IL285928A (en) Fulvestrant formulations and methods of using them
GB201621818D0 (en) Cosmetic composition and use thereof
GB201706355D0 (en) Methods compositions and uses relating thereto
IL248934A0 (en) Topical formulations and their uses
GB201706356D0 (en) Methods compositions and uses relating thereto
IL268583A (en) Preparations and methods for use on the skin
IL265531A (en) N 3 -cyclically substituted thienouraciles and use thereof
GB201608762D0 (en) Compositions and uses thereof
GB201715785D0 (en) Methods compositions and uses relating thereto
GB201502268D0 (en) Dental composition and use
GB201715820D0 (en) Compositions and methods
GB201705626D0 (en) Compositions and methods
PT3373976T (pt) Formulações tópicas e suas utilizações
ZA201807665B (en) Methods and compositions
GB201614897D0 (en) Compositions and uses thereof
HK40002856A (en) Nitric oxide generating formulations and kits
GB201911959D0 (en) Immunogenic compositions and uses therefor